全膝关节置换术中维生素C预防复杂性区域疼痛综合征复发:960例倾向评分匹配分析
该回顾性单中心观察性队列研究纳入2017年1月至2021年12月1088例全膝关节置换术,经排除后467例接受维生素C预防(每日1克,共40天),571例未接受;经倾向评分1:1匹配后两组各480例,其中28例有复杂性区域疼痛综合征病史。匹配人群中维生素C组复杂性区域疼痛综合征发生率为6.9%(33/480),低于未用维生素C组的11.0%(53/480)(OR=0.59,95%CI 0.37至0.9,p=0.024);在有病史的28例中,维生素C组复发率为19%(4/21),低于未用组的71%(5/7)(OR=0.09,95%CI 0.01至0.64,p=0.02)。作者认为维生素C预防可能适用于预防全膝关节置换术后复杂性区域疼痛综合征,并强调其可降低有病史患者的复发率。
要点
- 匹配后维生素C组复杂性区域疼痛综合征发生率为6.9%(33/480),未用组为11.0%(53/480),OR=0.59(95%CI 0.37至0.9),p=0.024。
- 有复杂性区域疼痛综合征病史者发生率32%,无病史者8%,OR=5.4(95%CI 2.57至11.4),p<0.001。
- 有病史的28例中,维生素C组复发率19%(4/21),未用组71%(5/7),OR=0.09(95%CI 0.01至0.64),p=0.02。
核心结论
- 作者认为维生素C预防可能适用于预防全膝关节置换术后复杂性区域疼痛综合征。
- 作者认为该研究强调维生素C在降低有复杂性区域疼痛综合征病史患者全膝关节置换术后复发率方面的有益作用。
研究设计与样本
- 回顾性单中心观察性队列研究,采用倾向评分匹配,研究时间为2017年1月至2021年12月。
- 初始纳入1088例全膝关节置换术,其中49例为有复杂性区域疼痛综合征病史的患者;排除50例后,467例(45%)接受术后维生素C预防(每日1克,共40天),571例(55%)未接受。
- 按性别、年龄、体重指数、糖尿病和高血压、烟草和酒精使用、麻醉方式、止血带使用、焦虑和抑郁进行1:1匹配后,维生素C组和无维生素C组各480例,其中28例有复杂性区域疼痛综合征病史。
主要发现
- 倾向评分匹配人群中,维生素C预防组480例中6.9%(33例)发生复杂性区域疼痛综合征,未用维生素C组480例中11.0%(53例)发生(OR=0.59,95%CI 0.37至0.9,p=0.024)。
- 有复杂性区域疼痛综合征病史者发生率32%,无病史者8%(OR=5.4,95%CI 2.57至11.4,p<0.001)。
- 在有复杂性区域疼痛综合征病史的28例中,维生素C预防组复发率为19%(21例中4例),未用维生素C组为71%(7例中5例)(OR=0.09,95%CI 0.01至0.64,p=0.02)。
- 在匹配患者的多变量回归中,维生素C与全膝关节置换术后复杂性区域疼痛综合征复发率降低独立相关(OR=0.53,95%CI 0.3至0.86,p=0.011)。
关键数值与推荐
- 维生素C预防方案为每日1克,术后共40天。
- 证据等级为治疗性III级。
临床怎么用
- 作者认为维生素C预防可能适用于预防全膝关节置换术后复杂性区域疼痛综合征。
- 作者认为维生素C在降低有复杂性区域疼痛综合征病史患者全膝关节置换术后复发率方面有有益作用。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Several studies have investigated the risk of complex regional pain syndrome (CRPS) and its prevention with vitamin C. However, evidence regarding the effectiveness of vitamin C for prevention of CRPS development or recurrence after total knee arthroplasty (TKA) is lacking. METHODS: This retrospective single-center observational cohort study, which utilized propensity-score matching (PSM), was conducted from January 2017 to December 2021. It initially included 1,088 TKAs, 49 of which were in patients who had a previous CRPS. After exclusion of 50 TKAs, the study included 467 TKAs (45%) in patients who received vitamin C prophylaxis (1 g daily for 40 days) after surgery and 571 (55%) in patients who did not. After 1:1 matching on the basis of sex, age, body mass index, presence of diabetes mellitus and hypertension, use of tobacco and alcohol, anesthesia modality, tourniquet use, and anxiety and depression, the vitamin C group and the no-vitamin C group comprised 480 patients each. Twenty-eight of these 960 patients had a history of CRPS. RESULTS: In the PSM population, 6.9% (33) of the 480 patients who received vitamin C prophylaxis after TKA developed CRPS compared with 11.0% (53) of the 480 who did not receive vitamin C (odds ratio [OR] = 0.59 [95% confidence interval (CI), 0.37 to 0.9], p = 0.024). The rate of CRPS was significantly higher in patients with a history of CRPS (32% versus 8% for patients with no previous CRPS; OR = 5.4 [95% CI, 2.57 to 11.4], p < 0.001). In the 28 patients with a history of CRPS, vitamin C prophylaxis reduced the rate of CRPS recurrence after TKA to 19% (4 of 21) compared with 71% (5 of 7) in the patients not treated with vitamin C (OR = 0.09 [95% CI, 0.01 to 0.64], p = 0.02). In multivariable regression of the matched patients, vitamin C was also found to be independently associated with a lower rate of CRPS recurrence after TKA (OR = 0.53 [95% CI, 0.3 to 0.86], p = 0.011). CONCLUSIONS: Vitamin C prophylaxis may be appropriate for preventing CRPS after TKA. Furthermore, the study highlights the beneficial role of vitamin C in reducing the rate of CRPS recurrence in patients with a history of CRPS who are undergoing TKA. LEVEL OF EVIDENCE: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
引用
- Hernigou J, Chahidi E, Everaert J, et al. Prophylaxis Against Complex Regional Pain Syndrome Recurrence with Vitamin C in Total Knee Arthroplasty: A Propensity Score-Matched Analysis of 960 Cases. J Bone Joint Surg Am. 2025. PMID: 40924823. doi:10.2106/JBJS.24.01584
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。